
Study Finds No Significant Driving Impairment in Frequent Cannabis Users 12–15 Hours After Use
Frequent cannabis users showed no significant driving impairment 12–15 hours after smoking, even with detectable THC, according to new research published in the Journal of Cannabis Research
Key Points
- 1Frequent cannabis users did not show significant driving impairment 12–15 hours after use
- 2Blood and oral fluid THC levels did not correlate with simulator driving performance
- 3The findings challenge the use of per se THC thresholds as a universal impairment standard
- 4Researchers emphasize the need for larger studies, especially with occasional users and real-world driving scenarios
A new study published in the Journal of Cannabis Research has found that frequent cannabis users show no significant driving impairment 12 to 15 hours after smoking, even when THC remains detectable in their systems. The research specifically targeted individuals who used cannabis at least four times per week, comparing their driving performance in a simulator to that of non-users matched by age, sex, driving experience, and sleep patterns. According to High Times, the study's design aimed to shed light on the contentious question of whether 'the morning after' cannabis use affects driving safety
The researchers recruited 65 frequent users and 65 non-users, bringing the cannabis group in for testing the morning after their last consumption. Participants completed both standard and more challenging 'dual task' simulated drives. The results revealed no statistically significant differences in driving performance between the two groups after correcting for multiple comparisons. Key measures such as speed, following distance, and the commonly cited 'weaving' metric—standard deviation of lateral position (SDLP)—did not indicate greater impairment among cannabis users; in fact, SDLP was slightly higher in the control group, though the difference was not significant
Importantly, the study found that THC was still detectable in the blood and oral fluid of frequent users the morning after smoking, with mean blood THC levels at 2.8 ng/mL and oral fluid THC averaging 31 ng/mL. However, the presence of THC did not correlate with impaired driving performance in the simulator. The researchers stated, 'blood and oral fluid THC concentrations may not be an accurate correlate of driving behavior,' emphasizing that their findings challenge the reliance on per se THC thresholds as a proxy for impairment
Despite these findings, the study comes with notable caveats. The results apply only to frequent users of smoked cannabis and may not translate to occasional users or other methods of consumption. Furthermore, all testing was conducted on a driving simulator rather than real roads, and subjective feelings of intoxication did not align with objective driving outcomes once statistical corrections were made
From the OG Lab newsroom's perspective, this research highlights the ongoing complexity in legislating cannabis and driving safety. As more regions consider or implement THC-based driving laws, these findings raise important questions about the validity of using THC presence alone as an indicator of impairment. For the cannabis industry and regulators alike, larger studies—especially involving occasional users and real-world driving—will be crucial in shaping fair and evidence-based policy